The state Board of Public Utilities has adopted a plan to help the solar industry transition to a new way of paying for solar projects, with the hope that it will result in lower costs for utility customers. But some solar companies are objecting.

Kenilworth-based Merck, a dominate player in immuno-oncology, has acquired a cancer drug maker in order to bolster its pipeline.

And New Jersey has a shortage of skilled machinists, but a new apprenticeship program seeks to change that.